T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more
T&L Co. Ltd - Asset Resilience Ratio
T&L Co. Ltd (340570) has an Asset Resilience Ratio of 33.68% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how T&L Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down T&L Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩73.82 Billion | 33.68% |
| Total Liquid Assets | ₩73.82 Billion | 33.68% |
Asset Resilience Insights
- Very High Liquidity: T&L Co. Ltd maintains exceptional liquid asset reserves at 33.68% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
T&L Co. Ltd Industry Peers by Asset Resilience Ratio
Compare T&L Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for T&L Co. Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for T&L Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 38.11% | ₩75.10 Billion | ₩197.08 Billion | +4.84pp |
| 2023-12-31 | 33.27% | ₩47.27 Billion | ₩142.11 Billion | +6.23pp |
| 2022-12-31 | 27.04% | ₩31.64 Billion | ₩117.00 Billion | -10.21pp |
| 2021-12-31 | 37.25% | ₩36.62 Billion | ₩98.31 Billion | -6.33pp |
| 2020-12-31 | 43.59% | ₩34.63 Billion | ₩79.45 Billion | +32.30pp |
| 2019-12-31 | 11.29% | ₩4.89 Billion | ₩43.32 Billion | +3.73pp |
| 2018-12-31 | 7.56% | ₩2.76 Billion | ₩36.53 Billion | +1.75pp |
| 2017-12-31 | 5.82% | ₩1.95 Billion | ₩33.57 Billion | -- |